We found a higher expression of SOD2 in patient PBMCs, which is in agreement with earlier studies reporting higher SOD2 gene expression in hemodialysis (46) and peritoneal dialysis patients (42) compared to healthy controls. The gene discussed is SOD2; the disease is kidney failure.